An independent guide to cash-pay care. Every price is dated and sourced.

How we check

Semaglutide in Atlanta: clinics and prices

Atlanta prescribers write semaglutide as Wegovy for weight and as Ozempic for type 2 diabetes. On Oct 17, 2026, NovoCare's cash list put Wegovy pens at $349 a month and Wegovy tablets from $149 [1]. Georgia Medicaid does not pay for either for weight loss alone [2].

Medical review: pending. A licensed clinician has not yet reviewed this page.

Semaglutide is a GLP-1 receptor agonist that slows stomach emptying and reduces appetite; Novo Nordisk sells it as Wegovy, Ozempic and Rybelsus.

Wegovy pen self-pay
$349/month (Oct 17 2026) [1]
Wegovy pill self-pay
$149 to $299/month [1]
Atlanta adult obesity
29.3% [3]
Atlanta median household income
$85,652 [4]
Georgia Medicaid
No obesity GLP-1 coverage per KFF [2]

A year of Wegovy against an Atlanta budget

Atlanta's median household income is $85,652 [4]. At the $349 self-pay price, twelve months of Wegovy pens is $4,188, about 4.9% of that income, before visit fees. New patients pay $199 for the first two fills of the 0.25 mg or 0.5 mg pen through Dec 31 2026 [1].

With 29.3% of adults in the city living with obesity [3], demand for cash-pay semaglutide is large. Our semaglutide cost page covers insurance and savings cards.

The box is a paid ad and is labeled that way. We do not endorse advertisers.

Semaglutide prices in one table

Checked Oct 17 2026
ProductApproved forSelf-paySource
Wegovy penWeight, heart risk, MASH$349/month[1]
Wegovy pillWeight (adults)$149 to $299/month[1]
Ozempic penType 2 diabetes$349 (up to 1 mg), $499 (2 mg)[5]
Wegovy via TrumpRxSame productFrom $199/month[6]
TrumpRx is a portal that routes buyers to manufacturer prices; it is cash only. See our TrumpRx guide.

Daily tablet or weekly shot

Wegovy tablets go down first thing in the morning, on an empty stomach, with 4 ounces of plain water or less; food and other pills wait 30 minutes [7]. The shot is once a week at any hour. The thyroid C-cell tumor boxed warning applies to both forms [7]. See pill vs injection.

Clinic vials in metro Atlanta

FDA called the semaglutide shortage over on Feb 21, 2025 [8]. Compounded vials still sold by some clinics have no FDA approval, and the agency had 990 adverse event reports about compounded semaglutide by May 31, 2026 [9]. Our compounded semaglutide explainer covers the rest. Physicians in Atlanta are licensed by the Georgia Composite Medical Board [10].

Before the first dose

On the Wegovy label, 44% of people on 2.4 mg reported nausea (16% on placebo) and 30% reported diarrhea (16% on placebo). Belly pain that is severe and does not ease means stop and get checked. Lows are likelier for anyone also on insulin or a sulfonylurea [7]. For face swelling or trouble breathing, dial 911.

Keep reading: the semaglutide guide, finding semaglutide nearby, tirzepatide in Atlanta, and neighbors Charlotte and Nashville.

Questions people ask

What do Atlanta cash buyers pay for Wegovy?

NovoCare listed the pen at $349 a month on Oct 17, 2026, and a newcomer pays $199 for each of two starter fills until Dec 31, 2026 [1].

Do Wegovy tablets cost less than the pen?

At lower strengths, yes: 1.5 mg is $149, 4 mg is $199, and 9 or 25 mg is $299 a month, against $349 for any pen dose [1].

Will Georgia Medicaid pay for Wegovy for weight?

No. Georgia was outside the 13 Medicaid programs KFF found covering obesity GLP-1s in January 2026 [2].

How common is obesity inside Atlanta city limits?

CDC PLACES put adult obesity in the city of Atlanta at 29.3% for 2023 [3].

Where do I check an Atlanta doctor's license?

The Georgia Composite Medical Board licenses physicians statewide, Atlanta included [10].

Does TrumpRx sell Wegovy?

TrumpRx is a cash portal, not a pharmacy. It lists the Wegovy pen from $199 a month, needs a valid prescription, and hands buyers to the maker's channel [6].

Is compounded semaglutide the same as Wegovy?

No. It is not FDA-approved, and FDA logged 990 adverse event reports about compounded semaglutide through May 31, 2026 [9]. STEP 1 results (a 14.9% average loss at 68 weeks on 2.4 mg, 2.4% on placebo) came from brand semaglutide [11].

Sources

11 cited
  1. Wegovy self-pay offer. Novo Nordisk (NovoCare Pharmacy), Oct 17, 2026.
  2. Medicaid Coverage of and Spending on GLP-1s. KFF, Jan 16, 2026.
  3. PLACES: Place Data, Atlanta (2025 release, BRFSS 2023). CDC, 2023.
  4. QuickFacts: Atlanta city, Georgia. U.S. Census Bureau, 2025.
  5. Ozempic self-pay pricing. Novo Nordisk (NovoCare Pharmacy), Oct 17, 2026.
  6. TrumpRx.gov. U.S. government, Oct 17, 2026.
  7. Wegovy label (injection and tablets). DailyMed, National Library of Medicine, Jun 2026.
  8. FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize. U.S. Food and Drug Administration, Apr 1, 2026.
  9. FDA's concerns with unapproved GLP-1 drugs used for weight loss. U.S. Food and Drug Administration, Oct 1, 2026.
  10. Georgia Composite Medical Board. State of Georgia, accessed 2026-10-17.
  11. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine (PubMed), Feb 10, 2021.

This page is general information, not medical advice. Talk with a licensed clinician about your own care.

See semaglutide prices